200 related articles for article (PubMed ID: 34798981)
1. Pancreatic Cancer Surveillance and Novel Strategies for Screening.
Dudley B; Brand RE
Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):13-25. PubMed ID: 34798981
[TBL] [Abstract][Full Text] [Related]
2. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
[TBL] [Abstract][Full Text] [Related]
3. Screening and Surveillance for Pancreatic Adenocarcinoma in High-Risk Individuals.
Labiner AJ; Aronson A; Lucas AL
Hematol Oncol Clin North Am; 2022 Oct; 36(5):929-942. PubMed ID: 36265991
[TBL] [Abstract][Full Text] [Related]
4. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
Vasen H; Ibrahim I; Ponce CG; Slater EP; Matthäi E; Carrato A; Earl J; Robbers K; van Mil AM; Potjer T; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bergman W; Wasser M; Morreau H; Klöppel G; Schicker C; Steinkamp M; Figiel J; Esposito I; Mocci E; Vazquez-Sequeiros E; Sanjuanbenito A; Muñoz-Beltran M; Montans J; Langer P; Fendrich V; Bartsch DK
J Clin Oncol; 2016 Jun; 34(17):2010-9. PubMed ID: 27114589
[TBL] [Abstract][Full Text] [Related]
5. Surveillance for pancreatic cancer in high-risk individuals.
Konings ICAW; Canto MI; Almario JA; Harinck F; Saxena P; Lucas AL; Kastrinos F; Whitcomb DC; Brand RE; Lachter J; Malleo G; Paiella S; Syngal S; Saltzman JR; Stoffel EM; van Hooft JE; Hruban RH; Poley JW; Fockens P; Goggins MG; Bruno MJ;
BJS Open; 2019 Oct; 3(5):656-665. PubMed ID: 31592073
[TBL] [Abstract][Full Text] [Related]
6. High Growth Rate of Pancreatic Ductal Adenocarcinoma in
Ibrahim IS; Wasser MN; Wu Y; Inderson A; de Vos Tot Nederveen Cappel WH; Morreau H; Hes FJ; Veenendaal RA; Putter H; Feshtali S; van Mil AM; Gruis NA; Tollenaar RA; Bergman W; Bonsing BA; Vasen HFA
Cancer Prev Res (Phila); 2018 Sep; 11(9):551-556. PubMed ID: 29991580
[No Abstract] [Full Text] [Related]
7. Long-term yield of pancreatic cancer surveillance in high-risk individuals.
Overbeek KA; Levink IJM; Koopmann BDM; Harinck F; Konings ICAW; Ausems MGEM; Wagner A; Fockens P; van Eijck CH; Groot Koerkamp B; Busch ORC; Besselink MG; Bastiaansen BAJ; van Driel LMJW; Erler NS; Vleggaar FP; Poley JW; Cahen DL; van Hooft JE; Bruno MJ;
Gut; 2022 Jun; 71(6):1152-1160. PubMed ID: 33820756
[TBL] [Abstract][Full Text] [Related]
8. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals.
Kulkarni NM; Mannelli L; Zins M; Bhosale PR; Arif-Tiwari H; Brook OR; Hecht EM; Kastrinos F; Wang ZJ; Soloff EV; Tolat PP; Sangster G; Fleming J; Tamm EP; Kambadakone AR
Abdom Radiol (NY); 2020 Mar; 45(3):729-742. PubMed ID: 31768594
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic Cancer Surveillance in Carriers of a Germline
Klatte DCF; Boekestijn B; Wasser MNJM; Feshtali Shahbazi S; Ibrahim IS; Mieog JSD; Luelmo SAC; Morreau H; Potjer TP; Inderson A; Boonstra JJ; Dekker FW; Vasen HFA; van Hooft JE; Bonsing BA; van Leerdam ME
J Clin Oncol; 2022 Oct; 40(28):3267-3277. PubMed ID: 35658523
[TBL] [Abstract][Full Text] [Related]
10. Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry.
Del Chiaro M; Zerbi A; Capurso G; Zamboni G; Maisonneuve P; Presciuttini S; Arcidiacono PG; Calculli L; Falconi M;
Dig Liver Dis; 2010 Sep; 42(9):597-605. PubMed ID: 20627831
[TBL] [Abstract][Full Text] [Related]
11. Standardization of MRI Screening and Reporting in Individuals With Elevated Risk of Pancreatic Ductal Adenocarcinoma: Consensus Statement of the PRECEDE Consortium.
Huang C; Simeone DM; Luk L; Hecht EM; Khatri G; Kambadakone A; Chandarana H; Ream JM; Everett JN; Guimaraes A; Liau J; Dasyam AK; Harmath C; Megibow AJ;
AJR Am J Roentgenol; 2022 Dec; 219(6):903-914. PubMed ID: 35856454
[TBL] [Abstract][Full Text] [Related]
12. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
[TBL] [Abstract][Full Text] [Related]
13. Predisposing factors for pancreatic adenocarcinoma: What is the role of imaging?
Vullierme MP; Lagadec M
Diagn Interv Imaging; 2016 Dec; 97(12):1233-1240. PubMed ID: 27816353
[TBL] [Abstract][Full Text] [Related]
14. Incidental findings in pancreas screening programs for high-risk individuals: Results from three European expert centers.
Ibrahim IS; Brückner C; Carrato A; Earl J; Inderson A; de Vos Tot Nederveen Cappel WH; Mintziras I; Matthäi E; Figiel J; Wasser M; Moreau H; Bonsing B; Slater EP; Bartsch DK; Vasen HF
United European Gastroenterol J; 2019 Jun; 7(5):682-688. PubMed ID: 31210946
[TBL] [Abstract][Full Text] [Related]
15. Surveillance Outcome and Genetic Findings in Individuals at High Risk of Pancreatic Cancer.
Rosner G; Scapa E; Ziv T; Gluck N; Ben-Yehoyada M
Clin Transl Gastroenterol; 2024 Feb; 15(2):e00668. PubMed ID: 38147532
[TBL] [Abstract][Full Text] [Related]
16. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
[TBL] [Abstract][Full Text] [Related]
17. Surveillance for individuals at high-risk of pancreatic cancer: Are we finally heading toward evidence?
Capurso G
United European Gastroenterol J; 2019 Apr; 7(3):341-342. PubMed ID: 31019701
[No Abstract] [Full Text] [Related]
18. Late-Stage Pancreatic Cancer Detected During High-Risk Individual Surveillance: A Systematic Review and Meta-Analysis.
Chhoda A; Vodusek Z; Wattamwar K; Mukherjee E; Gunderson C; Grimshaw A; Sharma A; Ahuja N; Kastrinos F; Farrell JJ
Gastroenterology; 2022 Mar; 162(3):786-798. PubMed ID: 34813861
[TBL] [Abstract][Full Text] [Related]
19. Dilemmas in the management of screen-detected lesions in patients at high risk for pancreatic cancer.
Ibrahim IS; Bonsing BA; Swijnenburg RJ; Welling L; Veenendaal RA; Wasser MN; Morreau H; Inderson A; Vasen HF
Fam Cancer; 2017 Jan; 16(1):111-115. PubMed ID: 27406244
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with cancer worries in individuals participating in annual pancreatic cancer surveillance.
Konings IC; Harinck F; Kuenen MA; Sidharta GN; Kieffer JM; Aalfs CM; Poley JW; Smets EM; Wagner A; van Rens A; Vleggaar FP; Ausems MG; Fockens P; van Hooft JE; Bruno MJ; Bleiker EM;
Fam Cancer; 2017 Jan; 16(1):143-151. PubMed ID: 27629874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
